<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<rss version="2.0">
	<channel>
		<title>Advance Life Sciences (OTC:ADLS) Climbs Higher On News and Pending FDA Decision</title>
		<description>Comments for Advance Life Sciences (OTC:ADLS) Climbs Higher On News and Pending FDA Decision at http://www.biomedreports.com , comment 1 to 4 out of 4 comments</description>
		<link>http://www.biomedreports.com</link>
		<lastBuildDate>Wed, 08 Feb 2012 17:10:58 +0100</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200905301085/advance-life-sciences-otcadls-climbing-higher-on-news-and-pending-fda-decision.html#comment-134</link>
			<description>NDA to recommend the Restanza - Dr. Johnson</description>
			<pubDate>Tue, 02 Jun 2009 02:59:19 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200905301085/advance-life-sciences-otcadls-climbing-higher-on-news-and-pending-fda-decision.html#comment-126</link>
			<description>My credentials. Are as follows.
Family Practice Physician for eight years.
Four years in the Air Force as a Family Physician.
I was head of Avian Flu and Vaccination Program in Area of Responsibility in Kuwait during some phases of IRAQI Freedom.

I do not know much about the FINANCIAL SYSTEM or the STOCK MARKET. Though after following this stock for two years I have learned some.


SO HERE ARE THE PROS for this ANTBX.

1) Effective against CAP.
2) Effective for prophylaxis of exposure to Anthrax.
3) No C.diff side effect like AVELOX and LEVAQUIN.
(TRUST ME THIS IS A BIG DEAL. HAPPENS IN MY PRACTICE WAY TO OFTEN)
4) Probably more effective against Strep Pneumo than Zithromax, possibly BIAXIN.
5) No shown Hepatoxity.
6) No QT prologation like AVELOX and LEVAQUIN.
7) Once a day dosing.
8) High concentration in Lung tissues.
9) Effective against a broad Range of BIOTERRORISM AGENTS.

CONS ( AND I MEAN THIS )
1) COUSIN of the BLACK SHEEP of the FAMILY KETEK.
2) Possible Hangover with FDA from KETEK.
HOWEVER KETEK is STILL APPROVED BY FDA but with BLACK BOX WARNING.
PEOPLE FORGET THOUGH THAT LEVAQUIN AND AVELOX have black boz warning as well.


I am less qualified in the following areas but this is what I KNOW ABOUT THE financial side.

PROS-
1) Abbot will likely have to pay us something or we will not have to pay abbot 30 million at approval due to Abbot screwing up the Patent in INDIA.

2) low Market CAP, has a lot a room to move upward.

CONS-
we are broke.



ALL IN ALL I GIVE US A 5 to 1 odds of success. ANd SUCCESS to me mean 4-7 dollar a share price in three months.  - M.E.Garza</description>
			<pubDate>Sat, 30 May 2009 20:42:17 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200905301085/advance-life-sciences-otcadls-climbing-higher-on-news-and-pending-fda-decision.html#comment-122</link>
			<description>The statement is TRUE, it is good news that there were no unexpected safety concerns.

&quot; Studies involving Advanced Life Sciences Holdings Inc.'s pneumonia drug revealed no unexpected safety concerns.&quot;

Safety was the main concern for many investors and with this out of the way the only other thing is effiecy and the data already shows that it is &quot;non inferior&quot; according to the FDA guidance.

[b][/b] - Dr. Jay</description>
			<pubDate>Sat, 30 May 2009 07:32:10 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200905301085/advance-life-sciences-otcadls-climbing-higher-on-news-and-pending-fda-decision.html#comment-121</link>
			<description>&quot;
The stock rose +42.42 % on Friday after getting good news from Food and Drug Administration scientists on Friday. 
&quot;
This is not true, the company merely sold materials for coming meeting and they were UPLOADED on the FDA web so anybody can read them. Nothing more. Really good news.  - beoX</description>
			<pubDate>Sat, 30 May 2009 02:34:32 +0100</pubDate>
		</item>
	</channel>
</rss>

